ASPIRE BIOPHARMA HOLDINGS, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $0 | — |
| FY2022 | — | $-9.9M | $497.3K |
| FY2023 | — | $-487.9K | $11.2K |
| FY2024 | — | $-1.5M | $3.6K |
| FY2025 | — | $-6.4M | $1.0M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $0 | — |
| FY2022 | — | $-9.9M | $497.3K |
| FY2023 | — | $-487.9K | $11.2K |
| FY2024 | — | $-1.5M | $3.6K |
| FY2025 | — | $-6.4M | $1.0M |